SCAVIT-K2: Phase II Randomized Placebo-controlled Study With Vitamin K2 in Asymptomatic Calcified Carotid Stenosis
Sponsor
Azienda Ospedaliera Sant'Anna (Other)
Overall Status
Unknown status
CT.gov ID
NCT01923012
Collaborator
(none)
200
1
24
Study Details
Study Description
Brief Summary
Randomized placebo-controlled study with vitamine K2 (Menaquinone-4) in calcified carotid stenosis. We evaluate the plaque remodelling after administration of vitamine, reducing the calcified component.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 2 |
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
200 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Phase 2 Study Randomized Placebo Controlled With Vitamin K2 in Asymptomatic Calcified Carotid Stenosis
Study Start Date
:
Sep 1, 2013
Anticipated Primary Completion Date
:
Sep 1, 2014
Anticipated Study Completion Date
:
Sep 1, 2015
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Vitamin K2
|
Drug: Vitamin K2 (Menaquinone)
|
Outcome Measures
Primary Outcome Measures
- Percentage reduction in plaque calcification and carotid stenosis [One year]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- carotid stenosis between 50 and 70% (NASCET criteria) with calcified plaque
Exclusion Criteria:
-
renal and/or hepatic failure
-
diseases with secondary calcifications
-
dementia
-
previous strokes
-
concomitant use of anticoagulants
-
concomitant infections
-
pregnancy or breastfeeding
-
reduced patient's compliance
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Azienda Ospedaliera Sant'Anna
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Simone Vidale,
Medical Doctor,
Azienda Ospedaliera Sant'Anna
ClinicalTrials.gov Identifier:
NCT01923012
Other Study ID Numbers:
- OSA-0001
First Posted:
Aug 14, 2013
Last Update Posted:
May 28, 2014
Last Verified:
May 1, 2014